Ivermectin as a Novel Therapy in COVID-19 Treatment
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 40
Summary
- Conditions
- COVID
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Clinical Study Evaluating the Efficacy of Ivermectin in COVID-19 treatment
Clinical Study Evaluating the Efficacy of Ivermectin in COVID-19 treatment
Tracking Information
- NCT #
- NCT04403555
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: sherief Abd-Elsalam, Ass. Prof. ass. Prof. Tropical Medicine
Get Well Soon